Guinness Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239M Sell
1,101,015
-72,165
-6% -$16M 4.12% 3
2025
Q4
$270M Sell
1,173,180
-37,113
-3% -$8.45M 4.38% 5
2025
Q3
$270M Buy
1,210,293
+4,268
+0.4% +$869K 4.3% 5
2025
Q2
$224M Buy
1,206,025
+17,575
+1% +$3.27M 4% 11
2025
Q1
$249M Sell
1,188,450
-31,927
-3% -$6.21M 4.73% 5
2024
Q4
$217M Buy
1,220,377
+60,598
+5% +$11.1M 4.08% 10
2024
Q3
$229M Buy
1,159,779
+50,735
+5% +$9.47M 4.33% 4
2024
Q2
$190M Sell
1,109,044
-134,532
-11% -$22.3M 3.92% 7
2024
Q1
$226M Sell
1,243,576
-17,274
-1% -$2.98M 4.71% 2
2023
Q4
$195M Buy
1,260,850
+910
+0.1% +$133K 4.27% 2
2023
Q3
$188M Buy
1,259,940
+327,755
+35% +$48.1M 4.32% 3
2023
Q2
$126M Buy
932,185
+75,525
+9% +$11.1M 2.91% 19
2023
Q1
$137M Buy
856,660
+84,137
+11% +$12.9M 3.47% 9
2022
Q4
$125M Sell
772,523
-225,323
-23% -$34.5M 3.51% 9
2022
Q3
$134M Buy
997,846
+209,932
+27% +$30.1M 4.57% 1
2022
Q2
$121M Buy
787,914
+72,809
+10% +$11.1M 4.75% 1
2022
Q1
$116M Buy
715,105
+26,841
+4% +$3.9M 4.31% 1
2021
Q4
$93.2M Buy
688,264
+103,447
+18% +$12.2M 3.64% 3
2021
Q3
$73.1M Buy
584,817
+97,357
+20% +$11.1M 3.46% 4
2021
Q2
$54.9M Buy
487,460
+1,270
+0.3% +$143K 3.02% 15
2021
Q1
$52.6M Sell
486,190
-5,900
-1% -$631K 3.31% 8
2020
Q4
$52.7M Buy
492,090
+112,540
+30% +$10.8M 3.82% 7
2020
Q3
$33.2M Buy
379,550
+4,060
+1% +$382K 3.48% 15
2020
Q2
$36.9M Sell
375,490
-56,400
-13% -$4.97M 4.36% 4
2020
Q1
$32.9M Buy
431,890
+7,500
+2% +$639K 4.77% 6
2019
Q4
$37.6M Buy
424,390
+20,300
+5% +$1.69M 4.59% 11
2019
Q3
$30.6M Buy
404,090
+112,040
+38% +$7.68M 4.64% 3
2019
Q2
$21.2M Buy
292,050
+71,840
+33% +$5.65M 3.45% 14
2019
Q1
$17.7M Hold
220,210
3.02% 13
2018
Q4
$20.3M Buy
220,210
+54,840
+33% +$4.82M 4.15% 4
2018
Q3
$15.6M Buy
165,370
+19,710
+14% +$1.87M 2.83% 14
2018
Q2
$13.5M Buy
145,660
+29,910
+26% +$2.92M 2.64% 12
2018
Q1
$11M Sell
115,750
-19,350
-14% -$2.13M 2.41% 14
2017
Q4
$13.1M Sell
135,100
-40,790
-23% -$3.84M 2.74% 8
2017
Q3
$15.6M Hold
175,890
3.27% 2
2017
Q2
$12.8M Buy
175,890
+24,870
+16% +$1.67M 2.7% 5
2017
Q1
$9.84M Buy
151,020
+13,620
+10% +$856K 2.19% 25
2016
Q4
$8.6M Buy
137,400
+38,390
+39% +$2.34M 2.07% 21
2016
Q3
$6.25M Buy
99,010
+4,400
+5% +$285K 1.57% 35
2016
Q2
$5.86M Buy
94,610
+19,090
+25% +$1.16M 1.61% 23
2016
Q1
$4.31M Buy
75,520
+2,800
+4% +$156K 1.31% 33
2015
Q4
$4.31M Hold
72,720
1.76% 19
2015
Q3
$3.96M Hold
72,720
1.84% 25
2015
Q2
$4.89M Buy
72,720
+4,840
+7% +$316K 1.88% 20
2015
Q1
$3.97M Buy
67,880
+18,300
+37% +$1.11M 1.86% 27
2014
Q4
$3.25M Sell
49,580
-4,840
-9% -$305K 1.6% 22
2014
Q3
$3.14M Buy
54,420
+3,470
+7% +$193K 1.33% 23
2014
Q2
$2.88M Buy
50,950
+8,800
+21% +$462K 1.12% 23
2014
Q1
$2.17M Buy
42,150
+900
+2% +$45.5K 1.32% 34
2013
Q4
$2.18M Buy
41,250
+2,570
+7% +$126K 1.35% 28
2013
Q3
$1.73M Buy
38,680
+20,360
+111% +$903K 1.07% 33
2013
Q2
$757K Buy
+18,320
New +$801K 0.58% 43

Other funds holding ABBV

Guinness Asset Management's ABBV Position: Q1 2026 in Review

Guinness Asset Management reduced its AbbVie (ABBV) stake by 6.2% in Q1 2026, selling an estimated $16M and leaving 1,101,015 shares worth $239M. The position accounts for 4.12% of the portfolio, ranked #3.

Guinness Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $270M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Guinness Asset Management held 1,101,015 shares of AbbVie worth $239M as of Q1 2026.
  • Guinness Asset Management sold 72,165 AbbVie shares in Q1 2026, an estimated $16M.
  • AbbVie made up 4.12% of Guinness Asset Management's portfolio in Q1 2026, its #3 holding.
  • Guinness Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Guinness Asset Management's AbbVie position peaked at $270M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Guinness Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.